Innovations in Acute Myeloid Leukemia Drugs, Neurological Disorder Treatment, Solar Cells, Flexible Electronics, and Digital Forensics

Share this:
Published: 13 Jul 2018

This edition of the Inside R&D TOE depicts developments associated with acute myeloid leukemia drugs and neurological disorder treatment. It also focuses on innovations in solar cells, flexible electronics, and digital forensics. Inside R&D TechVision Opportunity Engine (TOE) covers global innovations that are in research and development in virtually all technology areas. We provide intelligence and insights on innovations spanning a wide variety of industry areas, including automation, electronics, sensors, information and communication technologies, manufacturing, health, wellness, medical devices, pharma, biotechnology, materials, coatings, renewable fuels, automotive, power systems, sustainable energy solutions and innovations that contribute to a cleaner and greener environment. Keywords: Acute myeloid leukemia, AML, schizophrenia, biogenic solar cell, conductive film, digital forensics



Features of this research


Help Desk

Full list of offices

For more information and general enquiries, contact Frost & Sullivan near you.

North America
tel: +1.877.463.7678

Select a location near you..